Somewhat Favorable Media Coverage Somewhat Unlikely to Affect Uroplasty (UPI) Share Price

Press coverage about Uroplasty (NASDAQ:UPI) has trended somewhat positive this week, according to Accern. Accern identifies negative and positive media coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Uroplasty earned a news impact score of 0.15 on Accern’s scale. Accern also assigned media coverage about the medical device company an impact score of 44.4797587177133 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

These are some of the news headlines that may have impacted Accern Sentiment Analysis’s scoring:

Uroplasty (UPI) opened at $1.22 on Wednesday. Uroplasty has a 12 month low of $1.05 and a 12 month high of $4.05.

ILLEGAL ACTIVITY WARNING: “Somewhat Favorable Media Coverage Somewhat Unlikely to Affect Uroplasty (UPI) Share Price” was first posted by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are viewing this piece of content on another website, it was illegally copied and reposted in violation of U.S. and international trademark and copyright law. The original version of this piece of content can be viewed at https://www.chaffeybreeze.com/2017/12/06/somewhat-favorable-media-coverage-somewhat-unlikely-to-affect-uroplasty-upi-share-price.html.

Uroplasty Company Profile

Cogentix Medical, Inc (Cogentix Medical) is a medical device company. The Company is engaged in the design, development, manufacturing and marketing of products for endoscopy with its product lines featuring a visualization system and sterile disposable microbial barrier, known as EndoSheath technology, providing users with endoscope turnover.

Receive News & Ratings for Uroplasty Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Uroplasty Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply